ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal

Core Viewpoint - Institutional Shareholder Services has recommended that shareholders approve Kimberly-Clark's plans to acquire Kenvue, indicating that the merger could enhance financial metrics for the company [1] Group 1 - The acquisition involves Kimberly-Clark, known for its Kleenex brand, seeking to purchase Kenvue, the maker of Tylenol [1] - The recommendation from Institutional Shareholder Services suggests a positive outlook on the potential benefits of the merger for Kimberly-Clark's financial performance [1]